HLHaitao Li

Haitao Li

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Haitao Li has a total of 1000 co-authors. Here are the top co-authors by number of shared publications:

  • Yuanyuan Li

    State Key Laboratory of Molecular Oncology, MOE Key Laboratory of Protein Sciences, Beijing Frontier Research Center for Biological Structure, School of Basic Medical Sciences, Tsinghua University, Beijing 100084, China

    22 shared publications
  • C. David Allis

    Laboratory of Chromatin Biology & Epigenetics, The Rockefeller University

    15 shared publications
  • Liling Wan

    Department of Cancer Biology, University of Pennsylvania Perelman School of Medicine, Philadelphia, USA

    15 shared publications
  • Shuai Zhao

    MOE Key Laboratory of Protein Sciences, Beijing Advanced Innovation Center for Structural Biology, Department of Basic Medical Sciences, School of Medicine, Tsinghua University, Beijing 100084, China; Tsinghua-Peking Joint Center for Life Sciences, Tsinghua University, Beijing 100084, China

    13 shared publications
  • Xiaobing Shi

    Center for Epigenetics, Van Andel Institute, Grand Rapids, USA

    12 shared publications
  • Dan Zhao

    MOE Key Laboratory of Protein Sciences, Beijing Advanced Innovation Center for Structural Biology, Department of Basic Medical Sciences, School of Medicine, Tsinghua University, Beijing 100084, China; Tsinghua-Peking Center for Life Sciences, Tsinghua University, Beijing 100084, China

    11 shared publications

Latest Publications

  • Open Access

    Enhancers Silence Coupled Coding RNAs in Animals

    by Lingbo Li, Song Mei, Haolin Liu, Xinjian Liu, Qianqian Zhang, Ernesto Guccione, Haitao Li, Chuanyuan Li, Gongyi Zhang

    The exact working mechanism and biogenesis of regulatory non-coding RNAs (rncRNAs), including enhancer RNAs (eRNAs), microRNAs (miRNAs), piRNAs, small interfering RNAs (siRNAs), transposons, and other non-coding RNAs, remain enigmatic. Conversely, the unique transcriptional regulation mechanism that differentiates animals from simple unicellular organisms remains elusive in life sciences. We find that regulatory non-coding genes are independent transcription units marked with arginine methylation of nucleosomes within their gene bodies, which is regulated by JMJD5. Enhancer RNAs are similar to those of other regulatory RNAs in targeting the 3’UTRs of coupled coding RNAs. All regulatory RNA genes share transcription factors with their target coding genes, both of which are regulated by promoter-proximal RNA Polymerase II pausing and may control the development of animals. Temporal and spatial coding genes and regulatory non-coding genes are intrinsically coupled in animals.

  • Open Access

    KMT2E recruitment by H3 serotonylation regulates neurodevelopmental chromatin dynamics

    by Jennifer C O’Chan, Benjamin H. Weekley, Celi Yang, Min Chen, Ashley M. Cunningham, Sohini Dutta, Winnie Chen, Rasika R. Iyer, Newaz I. Ahmed, Bulent Cetin, et al.

    Histone H3 Gln 5 serotonylation (H3Q5ser) is a recently identified epigenetic modification in brain that modulates reader interactions with adjacent H3 Lys 4 trimethylation (H3K4me3) to promote transcriptional permissiveness 1,2 . However, whether H3K4me3Q5ser and its associated binding proteins regulate neurodevelopmental gene expression programs remains unknown. Here, we identified the catalytically inactive Lysine methyltransferase 2E (KMT2E) as a reader of combinatorial H3K4me3Q5ser. KMT2E preferentially binds H3K4me3Q5ser over H3K4me3 alone, and enriches at broad chromatin domains marking actively transcribed neurodevelopmental loci. Notably, heterozygous variants in KMT2E have been implicated in ODLURO syndrome, a recently characterized neurodevelopmental disorder (NDD) 3,4 . To identify the molecular mechanisms underlying ODLURO syndrome, we generated a Kmt2e transgenic mouse model that reproduces behavioral, physiological, and cellular endophenotypes associated with this and other NDDs. Furthermore, we observed that KMT2E mediates these effects by recruiting the NCoR/HDAC3 repressor complex to H3K4me3Q5ser-marked loci to restrict spreading of co-localized H3 Lys 9 acetylation (H3K9ac). Inhibition of aberrant H3K9ac spreading was sufficient to rescue transcriptional dysregulation in Kmt2e haploinsufficient neurons. These findings thus establish KMT2E as a critical reader of H3 serotonylation during neurodevelopment and provide mechanistic insights into the pathogenesis of ODLURO syndrome.


  • Open Access

    Discovery of High-Affinity Peptide Ligands Targeting the SPIN1 Tudor 3 Domain Via a Minimalist Pruning Strategy

    by Alessandra Feoli, Giulio Esposito, Manuela Grimaldi, Monica Viviano, Ida Pacilio, Josef KrátKý, Anna Maria D’URsi, Ciro Milite, Haitao Li, Mark T. Bedford, et al.

    Spindlin1 (SPIN1) is an epigenetic reader involved in oncology, whose third Tudor domain remains largely underexplored. Here, we applied a minimalist pruning strategy to the 26-mer peptide DOCpep3 to identify the core pharmacophore for SPIN1 Tudor 3 domain binding. This yielded truncated linear peptide analogues (e.g., 1, 3, and 4) displaying low nanomolar affinities, significantly outperforming the parent peptide. Orthogonal biophysical validation (MST and SPR) confirmed competitive target engagement. Furthermore, circular dichroism spectroscopy revealed that these pruned ligands induce distinct structural rearrangements in SPIN1, establishing high-affinity chemical probes for drug discovery.

  • Open Access

    RNA reinforces condensate nucleation on chromatin to amplify oncogenic transcription

    by Krista A. Budinich, Xinyi Yao, Chujie Gong, Lele Song, Xiaoting Wang, Michelle C. Lee, Kaeli M. Mathias, Qinglan Li, Sylvia Tang, Yiman Liu, et al.


  • Open Access

    AF9-KLF2 gene regulatory circuit links histone lactylation to metabolic reprogramming and breast cancer progression

    by Huida Ma, Ming Yuan, Chenxuan Yang, Yuchen Yuan, Yuanyuan Li, Xin Wang, Zhonghui Tang, Haitao Li


  • Open Access

    Quinone reductase 2 reads H3 serotonylation to support human cortical neuron development

    by Min Chen, Celi Yang, Xin Li, Lingchun Kong, Benjamin H. Weekley, Xiaoran Wei, Jennifer C O’CHan, David A. Vinson, Bulent Cetin, Aarthi Ramakrishnan, et al.

    Histone H3 Gln5 serotonylation (H3Q5ser) is a posttranslational modification that guides transcriptional permissiveness in the brain and periphery. Because it can co-occur with H3K4me3, prior studies focused on its modulation of H3K4me3 readers , leaving open whether H3Q5ser acts as an autonomous chromatin mark. Using proteomic, structural, molecular, epigenomic, and cellular approaches, we show that Quinone reductase 2 (QR2), previously known only as a cytosolic enzyme, reads H3Q5ser independently of H3K4me3. QR2 recognizes the serotonyl group through its FAD-dependent quinone-binding pocket, discriminating against unmodified H3, H3K4me3, and other monoaminyl marks. In human iPSC-derived neurons, CRISPR-Cas9 disruption of H3 serotonylation or QR2 binding impairs transcriptional programs, synaptic connectivity, and electrophysiological maturation. In cortical organoids, these disruptions cause progenitor over-proliferation at the expense of excitatory neurons and uncouple POU2F1-linked regulatory elements from the excitatory neuron maturation program. Together, these findings reveal an H3 serotonylation-QR2 signaling axis essential for human neurodevelopment.


  • Open Access

    CBFA2T2: a novel H3K27 reader regulating metabolism and tumor growth

    by Shengfei He, Yutian Ou, Fangfang Jiao, Jiuxing Feng, Ping Zhu, Jie Ma, Ning Xu, Haitao Li, Rui Guo

    Histone H3.3K27M mutations are identified in diffuse midline glioma (DMG), resulting in a global reduction in H3K27me3. Analyzing the histone recognition m

  • Discovery, Synthesis, and Biological Evaluation of Novel Quinoline-Based PDE4 Inhibitors with Potent Anti-Chronic Obstructive Pulmonary Disease Activity

    by Gang Xing, Yucong Bi, Zhenli Li, Zhengxing Zhi, Haitao Li, Maosheng Cheng

    Phosphodiesterase 4 (PDE4) is a key target for COPD anti-inflammatory drugs. The approved oral PDE4 inhibitor for COPD causes side effects such as nausea and vomiting due to high systemic exposure. Developing highly selective PDE4 inhibitors suitable for inhaled delivery represents an effective alternative strategy. Herein, we report the identification of P29, a PDE4 inhibitor exhibiting picomolar inhibitory potency (IC50 = 0.019 nM) and high selectivity (>10,000) over other PDEs. Subsequent studies demonstrated that P29 effectively suppressed LPS-induced TNF-α release in PBMCs. Notably, the fractions absorbed via pulmonary deposition and orally absorbed fractions were rapidly metabolized, reducing systemic exposure and minimizing adverse reactions. P29 significantly improved pulmonary function, inhibited inflammatory cell activity, reduced release of inflammatory cytokines, and ameliorated lung tissue damage in rat models of COPD induced by cigarette smoke and LPS. Collectively, our data highlight the therapeutic potential of P29 in COPD.


  • Complex-specific inhibitors for interrogating ATAC histone acetyltransferase complex

    by Sha Liu, Jinzhao Liu, Yinqiao Wu, Xinyi Yao, Xiang Li, Xinyu Dong, Qi Li, Hayden Jit Hei Cheung, Kwan Yuen Wong, Yuanyuan Li, et al.

    Histone acetyltransferases (HATs) modify chromatin to regulate gene expression. Instead of acting alone, HATs function in complexes with other proteins, leading to variations in substrate specificity, genomic localization and cellular function. To understand the complex-dependent roles of HATs, we present a chemical approach to specifically dissociate ATAC (Ada-two-A-containing) HAT complex from chromatin without perturbing other complexes. Rather than targeting the shared HAT enzyme, we developed chemical inhibitors for an ATAC-specific subunit, YEATS2. The most effective inhibitor, LS-170, specifically reduced the chromatin occupancy of the ATAC complex, decreased the ATAC-dependent histone acetylation level and downregulated the expression of ATAC-governed genes, leading to significantly suppressed tumor growth in a lung cancer mouse model. This study not only sheds light on the regulatory roles of the ATAC HAT complex in gene transcription but also provides evidence that the chemical inhibition of the ATAC complex can be a promising therapeutic strategy.


  • Open Access

    DNA–histone cross-link locks the nucleosome structure and disrupts its recognition and processing

    by Xiajing Shan, Gaoyuan Ji, Jiahui Li, Mengtian Ren, Jingke Ma, Yifei Zhou, Haitao Li, Chuanzheng Zhou

    DNA-histone cross-links (DHCs) frequently arise within nucleosomes during DNA damage and repair processes. However, the functional consequences of DHC within nucleosomes remain largely unexplored. In this study, we prepared structurally homogeneous nucleosomes containing a single, site-specific DHC using click chemistry and systematically evaluated the impact of DHC on nucleosome structure and function. Our results show that DHC markedly enhances nucleosome thermal stability and completely blocks both thermally induced passive sliding and chromatin remodeler-mediated active sliding. Moreover, DHC obstructs SP6 RNA polymerase-driven transcription elongation through nucleosomes, leading to premature termination approximately 15 bp upstream of the cross-linking site. DHC also increases histone resistance to proteolytic digestion within nucleosomes. These findings suggest that even a single DHC can substantially lock and rigidify the nucleosome structure and broadly interfere with the recognition and processing of nucleosomes by various cellular machineries, thereby rendering DHC a highly toxic and persistent form of DNA damage. This in vitro study highlights the unique impact of DHC on nucleosome architecture and is expected to motivate further exploration of its biological roles in vivo.